NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

纤维肌痛症(纤维肌痛症候群):全球临床实验趋势

Fibromyalgia (Fibromyalgia Syndrome) Disease - Global Clinical Trials Review, H2, 2020

出版商 GlobalData 商品编码 980201
出版日期 内容资讯 英文 307 Pages
订单完成后即时交付
价格
纤维肌痛症(纤维肌痛症候群):全球临床实验趋势 Fibromyalgia (Fibromyalgia Syndrome) Disease - Global Clinical Trials Review, H2, 2020
出版日期: 2020年12月30日内容资讯: 英文 307 Pages
简介

本报告提供全球纤维肌痛症(纤维肌痛症候群)相关临床研究最新趋势相关分析,疾病、治疗方法概要,及主要已开发国家、新兴国家 (G7/E7各国) 的临床实验状况,各地区、各期 (各相)、各阶段的进展,有潜力的赞助商 (临床试验赞助者),各企业及研究机关的研究进行状况,有潜力的药剂比较等资讯汇整。

目录

目录

表格一览

图表一览

  • 报告指南
  • 调查范围
  • 临床试验数量:各地区
  • 临床试验数量与平均登记数:各国
  • 亚太地区主要5个国家的临床试验数量
  • 欧洲主要5个国家的临床试验数量
  • 北美的主要国家的临床试验数量
  • 中东、非洲的主要国家的临床试验数量
  • 中南美主要5个国家的临床试验数量
  • G7各国临床试验数量:中枢神经系统的临床试验中纤维肌痛症(纤维肌痛症候群)的比例
  • G7各国的临床试验数量:各期
  • G7各国的临床试验数量:各临床实验状况
  • E7各国临床试验数量:中枢神经系统的临床试验的纤维肌痛症(纤维肌痛症候群)的比例
  • E7各国的临床试验数量:各期
  • E7各国的临床试验数量:各临床实验状况
  • 临床试验数量:各期
  • 进行中的实验数量:各期
  • 临床试验数量:各临床实验状况
  • 临床试验数量:各端点状态
  • 一定期间内募集的受验人数
  • 各赞助商类型临床试验数量
  • 有潜力的赞助商
  • 参加口腔炎治疗药物临床实验的主要企业
  • 有潜力的药剂
  • 临床试验专家的概述

附录

  • 简称
  • 定义
  • 调查方法
  • 2次调查
  • 关于GlobalData
  • 咨询方式
  • 资讯来源

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC6586CTIDB

GlobalData's clinical trial report, "Fibromyalgia (Fibromyalgia Syndrome) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Fibromyalgia (Fibromyalgia Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Fibromyalgia (Fibromyalgia Syndrome) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.*

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Fibromyalgia (Fibromyalgia Syndrome) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Fibromyalgia (Fibromyalgia Syndrome) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials by Region, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Fibromyalgia (Fibromyalgia Syndrome) to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Fibromyalgia (Fibromyalgia Syndrome) to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Fibromyalgia (Fibromyalgia Syndrome) to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Fibromyalgia (Fibromyalgia Syndrome) to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Fibromyalgia (Fibromyalgia Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology